Announced
Completed
XOMA Royalty-backed XenoTherapeutics completed the acquisition of Repare Therapeutics.
Synopsis
XOMA Royalty-backed XenoTherapeutics, a not-for-profit research organization, completed the acquisition of Repare Therapeutics, a clinical-stage precision oncology company. Financial terms were not disclosed.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2026 Datasite